Selected research
Market Structure
Global Diacylglycerol O Acyltransferase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Diacylglycerol O Acyltransferase 1 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Diacylglycerol O Acyltransferase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Diacylglycerol O Acyltransferase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Diacylglycerol O Acyltransferase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Diacylglycerol O Acyltransferase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Diacylglycerol O Acyltransferase 1 include Novartis AG, Merck & Co., Inc., Amgen Inc., Viking Therapeutics, Inc., Hanmi Pharmaceuticals, Co. Ltd. and Handok Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Diacylglycerol O Acyltransferase 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Diacylglycerol O Acyltransferase 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Diacylglycerol O Acyltransferase 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diacylglycerol O Acyltransferase 1 market size, projected growth trends, production technologies, key applications, and end-use industries.
Diacylglycerol O Acyltransferase 1 Segment by Company
Novartis AG
Merck & Co., Inc.
Amgen Inc.
Viking Therapeutics, Inc.
Hanmi Pharmaceuticals, Co. Ltd.
Handok Inc.
Diacylglycerol O Acyltransferase 1 Segment by Type
GSK-3008356
KR-69530
Others
Diacylglycerol O Acyltransferase 1 Segment by Application
Dyslipidemia
Gastrointestinantal
Metabolic Disorder
Others
Diacylglycerol O Acyltransferase 1 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diacylglycerol O Acyltransferase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diacylglycerol O Acyltransferase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diacylglycerol O Acyltransferase 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Diacylglycerol O Acyltransferase 1 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diacylglycerol O Acyltransferase 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diacylglycerol O Acyltransferase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Diacylglycerol O Acyltransferase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- GSK-3008356
- KR-69530
- Others
Applications
- Dyslipidemia
- Gastrointestinantal
- Metabolic Disorder
- Others
Companies covered
- Novartis AG
- Merck & Co., Inc.
- Amgen Inc.
- Viking Therapeutics, Inc.
- Hanmi Pharmaceuticals, Co. Ltd.
- Handok Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Diacylglycerol O Acyltransferase 1 Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Diacylglycerol O Acyltransferase 1 Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Diacylglycerol O Acyltransferase 1 Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Diacylglycerol O Acyltransferase 1 Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Diacylglycerol O Acyltransferase 1 Market Dynamics
- 2.1 Diacylglycerol O Acyltransferase 1 Industry Trends
- 2.2 Diacylglycerol O Acyltransferase 1 Industry Drivers
- 2.3 Diacylglycerol O Acyltransferase 1 Industry Opportunities and Challenges
- 2.4 Diacylglycerol O Acyltransferase 1 Industry Restraints
3 Diacylglycerol O Acyltransferase 1 Market by Manufacturers
- 3.1 Global Diacylglycerol O Acyltransferase 1 Revenue by Manufacturers (2021-2026)
- 3.2 Global Diacylglycerol O Acyltransferase 1 Sales by Manufacturers (2021-2026)
- 3.3 Global Diacylglycerol O Acyltransferase 1 Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Diacylglycerol O Acyltransferase 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Diacylglycerol O Acyltransferase 1 Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Diacylglycerol O Acyltransferase 1 Manufacturers, Product Type & Application
- 3.7 Global Diacylglycerol O Acyltransferase 1 Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Diacylglycerol O Acyltransferase 1 Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Diacylglycerol O Acyltransferase 1 Players Market Share by Revenue in 2025
- 3.8.3 2025 Diacylglycerol O Acyltransferase 1 Tier 1, Tier 2, and Tier 3
4 Diacylglycerol O Acyltransferase 1 Market by Type
- 4.1 Diacylglycerol O Acyltransferase 1 Type Introduction
- 4.1.1 GSK-3008356
- 4.1.2 KR-69530
- 4.1.3 Others
- 4.2 Global Diacylglycerol O Acyltransferase 1 Sales by Type
- 4.2.1 Global Diacylglycerol O Acyltransferase 1 Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Diacylglycerol O Acyltransferase 1 Sales by Type (2021-2032)
- 4.2.3 Global Diacylglycerol O Acyltransferase 1 Sales Market Share by Type (2021-2032)
- 4.3 Global Diacylglycerol O Acyltransferase 1 Revenue by Type
- 4.3.1 Global Diacylglycerol O Acyltransferase 1 Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Diacylglycerol O Acyltransferase 1 Revenue by Type (2021-2032)
- 4.3.3 Global Diacylglycerol O Acyltransferase 1 Revenue Market Share by Type (2021-2032)
5 Diacylglycerol O Acyltransferase 1 Market by Application
- 5.1 Diacylglycerol O Acyltransferase 1 Application Introduction
- 5.1.1 Dyslipidemia
- 5.1.2 Gastrointestinantal
- 5.1.3 Metabolic Disorder
- 5.1.4 Others
- 5.2 Global Diacylglycerol O Acyltransferase 1 Sales by Application
- 5.2.1 Global Diacylglycerol O Acyltransferase 1 Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Diacylglycerol O Acyltransferase 1 Sales by Application (2021-2032)
- 5.2.3 Global Diacylglycerol O Acyltransferase 1 Sales Market Share by Application (2021-2032)
- 5.3 Global Diacylglycerol O Acyltransferase 1 Revenue by Application
- 5.3.1 Global Diacylglycerol O Acyltransferase 1 Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Diacylglycerol O Acyltransferase 1 Revenue by Application (2021-2032)
- 5.3.3 Global Diacylglycerol O Acyltransferase 1 Revenue Market Share by Application (2021-2032)
6 Global Diacylglycerol O Acyltransferase 1 Sales by Region
- 6.1 Global Diacylglycerol O Acyltransferase 1 Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Diacylglycerol O Acyltransferase 1 Sales by Region (2021-2032)
- 6.2.1 Global Diacylglycerol O Acyltransferase 1 Sales by Region (2021-2026)
- 6.2.2 Global Diacylglycerol O Acyltransferase 1 Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Diacylglycerol O Acyltransferase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Diacylglycerol O Acyltransferase 1 Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Diacylglycerol O Acyltransferase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Diacylglycerol O Acyltransferase 1 Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Diacylglycerol O Acyltransferase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Diacylglycerol O Acyltransferase 1 Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Diacylglycerol O Acyltransferase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Diacylglycerol O Acyltransferase 1 Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Diacylglycerol O Acyltransferase 1 Revenue by Region
- 7.1 Global Diacylglycerol O Acyltransferase 1 Revenue by Region
- 7.1.1 Global Diacylglycerol O Acyltransferase 1 Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Diacylglycerol O Acyltransferase 1 Revenue by Region (2021-2026)
- 7.1.3 Global Diacylglycerol O Acyltransferase 1 Revenue by Region (2027-2032)
- 7.1.4 Global Diacylglycerol O Acyltransferase 1 Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Diacylglycerol O Acyltransferase 1 Revenue (2021-2032)
- 7.2.2 North America Diacylglycerol O Acyltransferase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Diacylglycerol O Acyltransferase 1 Revenue (2021-2032)
- 7.3.2 Europe Diacylglycerol O Acyltransferase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Diacylglycerol O Acyltransferase 1 Revenue (2021-2032)
- 7.4.2 Asia-Pacific Diacylglycerol O Acyltransferase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Diacylglycerol O Acyltransferase 1 Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Diacylglycerol O Acyltransferase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Novartis AG
- 8.1.1 Novartis AG Company Information
- 8.1.2 Novartis AG Business Overview
- 8.1.3 Novartis AG Diacylglycerol O Acyltransferase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Novartis AG Diacylglycerol O Acyltransferase 1 Product Portfolio
- 8.1.5 Novartis AG Recent Developments
- 8.2 Merck & Co., Inc.
- 8.2.1 Merck & Co., Inc. Company Information
- 8.2.2 Merck & Co., Inc. Business Overview
- 8.2.3 Merck & Co., Inc. Diacylglycerol O Acyltransferase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Merck & Co., Inc. Diacylglycerol O Acyltransferase 1 Product Portfolio
- 8.2.5 Merck & Co., Inc. Recent Developments
- 8.3 Amgen Inc.
- 8.3.1 Amgen Inc. Company Information
- 8.3.2 Amgen Inc. Business Overview
- 8.3.3 Amgen Inc. Diacylglycerol O Acyltransferase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Amgen Inc. Diacylglycerol O Acyltransferase 1 Product Portfolio
- 8.3.5 Amgen Inc. Recent Developments
- 8.4 Viking Therapeutics, Inc.
- 8.4.1 Viking Therapeutics, Inc. Company Information
- 8.4.2 Viking Therapeutics, Inc. Business Overview
- 8.4.3 Viking Therapeutics, Inc. Diacylglycerol O Acyltransferase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Viking Therapeutics, Inc. Diacylglycerol O Acyltransferase 1 Product Portfolio
- 8.4.5 Viking Therapeutics, Inc. Recent Developments
- 8.5 Hanmi Pharmaceuticals, Co. Ltd.
- 8.5.1 Hanmi Pharmaceuticals, Co. Ltd. Company Information
- 8.5.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
- 8.5.3 Hanmi Pharmaceuticals, Co. Ltd. Diacylglycerol O Acyltransferase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hanmi Pharmaceuticals, Co. Ltd. Diacylglycerol O Acyltransferase 1 Product Portfolio
- 8.5.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Developments
- 8.6 Handok Inc.
- 8.6.1 Handok Inc. Company Information
- 8.6.2 Handok Inc. Business Overview
- 8.6.3 Handok Inc. Diacylglycerol O Acyltransferase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Handok Inc. Diacylglycerol O Acyltransferase 1 Product Portfolio
- 8.6.5 Handok Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Diacylglycerol O Acyltransferase 1 Value Chain Analysis
- 9.1.1 Diacylglycerol O Acyltransferase 1 Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Diacylglycerol O Acyltransferase 1 Production Mode & Process
- 9.2 Diacylglycerol O Acyltransferase 1 Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Diacylglycerol O Acyltransferase 1 Distributors
- 9.2.3 Diacylglycerol O Acyltransferase 1 Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst